Zydus Lifesciences (ZYDUSLIFE) — Corporate Action

Zydus Lifesciences' wholly-owned subsidiary Zydus Foundation issued 4,50,000 equity shares of ₹10 each to Ramanbhai Foundation on November 19, 2025, ceasing to be a wholly-owned subsidiary. The Company retained 50,000 shares. Zydus Foundation contributed zero income and zero net worth to consolidated financials for FY2025, making this a non-material divestment. The share issuance was priced at fair value by a SEBI-registered valuer on an arm's-length basis.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this corporate action affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 19 November 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 19 November 2025

TATASTEEL Tata Steel Limited Financial Results BAJAJ-AUTO Bajaj Auto Limited Announcement CONCOR Container Corporation of India Limited Financial Results EICHERMOT Eicher Motors Limited Financial Results HEROMOTOCO Hero MotoCorp Limited Financial Results OFSS Oracle Financial Services Software Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.